SeaStar Medical Holding Corp (NASDAQ:ICU)
| Market Cap | 10.07M-46.1% |
| Revenue (ttm) | 1.71M+123.6% |
| Net Income | -13.63M+7.1% |
| EPS | -3.91+84.7% |
| Shares Out | 2.84M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 590,390 |
| Open | 3.62 |
| Previous Close | 4.69 |
| Day's Range | 3.44 - 3.73 |
| 52-Week Range | 2.07 - 7.35 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 8.00(+125.35%) |
| Earnings Date | Nov 12, 2026 |
SeaStar Medical Holding Corp has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
About ICU
SeaStar Medical Holding Corporation is a medical device company dedicated to providing innovative solutions and services designed to combat hyperinflammation and cytokine storm in critically ill individuals. The company specializes in developing and commercializing extracorporeal therapies that specifically target the immune 'effector cells' responsible for driving systemic inflammation, a process that directly harms tissues and releases a cascade of pro-inflammatory cytokines, thereby initiating and perpetuating dysregulated immune reactions. Its product pipeline spans various critical care areas, including acute kidney injury (both pediatric and adult) requiring continuous renal replacement therapy (CRRT), cardiorenal syndrome in patients with congestive heart failure (including those with or without LVADs), myocardial stunning in end-stage renal disease, and hepatorenal syndrome. The firm maintains its headquarters in Denver, Colorado.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$ICU stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in ICU holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by ICU's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
ICU Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New ICU patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to ICU from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in ICU
| ETF | Est. Holding Size |
|---|---|
| VXFVanguard Extended Market ETF | $103.24K |
| DXUVU.S. Vector Equity Portfolio ETF Class Shares | $17.52K |
| DFACDimensional - US Core Equity 2 ETF | $10.98K |
Estimated from each fund’s disclosed top holdings × AUM
ICU Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from ICU’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score